Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
69.35 EUR | +1.31% | -7.31% | -12.91% |
Apr. 26 | COMPUGROUP MEDICAL : Buy rating from Baader Bank | ZD |
Apr. 25 | COMPUGROUP MEDICAL : Jefferies gives a Neutral rating | ZD |
Sales 2024 * | 1.24B 1.33B | Sales 2025 * | 1.3B 1.4B | Capitalization | 1.52B 1.64B |
---|---|---|---|---|---|
Net income 2024 * | 93M 99.98M | Net income 2025 * | 117M 126M | EV / Sales 2024 * | 1.74 x |
Net Debt 2024 * | 641M 689M | Net Debt 2025 * | 556M 597M | EV / Sales 2025 * | 1.6 x |
P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
13.1
x | Employees | - |
Yield 2024 * |
2.27% | Yield 2025 * |
2.52% | Free-Float | 46.87% |
Latest transcript on CompuGroup Medical Societas Europaea
1 day | +1.31% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Rauch
CEO | Chief Executive Officer | 52 | 19-07-31 |
Frank Gotthardt
CEO | Chief Executive Officer | 72 | 86-12-31 |
Daniel Gotthardt
BRD | Director/Board Member | - | 03-08-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 61 | 20-06-17 | |
Director/Board Member | 59 | 20-06-17 | |
Klaus Esser
BRD | Director/Board Member | - | 03-05-25 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.86% | 325B | |
+25.01% | 214B | |
+0.97% | 149B | |
+14.31% | 58.18B | |
+6.02% | 31.42B | |
+6.58% | 30.71B | |
+99.08% | 22.51B | |
+27.94% | 20.66B | |
+7.14% | 13.72B |
- Stock Market
- Equities
- COP Stock
- COP Stock